Condensed Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Pledged assets	$ 3,881,078	$ 3,894,012
Pledged assets	99,496	148,820
Cash and cash equivalents	190,373	171,893
Restricted cash	13,247	28,396
Accrued interest receivable	15,614	14,951
Derivative assets	12,511	6,420
Other assets	2,343	455
Total Assets	4,214,662	4,264,947
LIABILITIES:
Repurchase agreements	3,711,498	3,705,649
Payable for investment securities and TBA transactions	395	60,454
Dividends payable	6,365	6,222
Derivative liabilities	80	12,694
Accrued interest payable	12,769	7,939
Other liabilities	917	1,031
Total Liabilities	3,733,031	3,795,002
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Preferred stock, $0.01 par value; 20,000,000 shares authorized; no shares issued and outstanding as of March 31, 2024 and December 31, 2023	0	0
Common Stock, $0.01 par value; 100,000,000 shares authorized, 52,826,169 shares issued and outstanding as of March 31, 2024 and 51,636,074 shares issued and outstanding as of December 31, 2023	528	516
Additional paid-in capital	841,790	849,845
Accumulated deficit	(360,657)	(380,433)
Accumulated other comprehensive (loss) income	(30)	17
Total Stockholders' Equity	481,631	469,945
Total Liabilities and Stockholders' Equity	4,214,662	4,264,947
Related Party [Member]
LIABILITIES:
Due to affiliates	$ 1,007	$ 1,013